Skip to Main Content

Author Details

Han Si
Hubei Engineering Research Center for Bio-enzyme Catalysis, Hubei University
2003
36
22
PMIDPaper TitleJournal TitlePublished Year
35308340Enabling Efficient Genetic Manipulations in a Rare Actinomycete <i>Pseudonocardia alni</i> Shahu.Front Microbiol2022
35308340Enabling Efficient Genetic Manipulations in a Rare Actinomycete <i>Pseudonocardia alni</i> Shahu.Front Microbiol2022
33355200A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.Clin Cancer Res2021
33257508A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade.Mol Cancer Res2021
33200847Brain-specific monoallelic expression of bovine UBE3A is associated with genomic position.Anim Genet2021
33355200A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.Clin Cancer Res2021
33200847Brain-specific monoallelic expression of bovine UBE3A is associated with genomic position.Anim Genet2021
33257508A New Pipeline to Predict and Confirm Tumor Neoantigens Predict Better Response to Immune Checkpoint Blockade.Mol Cancer Res2021
32817076Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment.Clin Cancer Res2020
32817076Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment.Clin Cancer Res2020
30955263[Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].Zhonghua Bing Li Xue Za Zhi2019
31684954The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.J Transl Med2019
31624067Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.Cancer Immunol Res2019
30955263[Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].Zhonghua Bing Li Xue Za Zhi2019
31684954The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.J Transl Med2019
31624067Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.Cancer Immunol Res2019
29518341Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.Am J Respir Crit Care Med2018
30380422Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.Cell Rep2018
29518341Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.Am J Respir Crit Care Med2018
30380422Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.Cell Rep2018
27132513TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.Oncogene2016
27147817RefCNV: Identification of Gene-Based Copy Number Variants Using Whole Exome Sequencing.Cancer Inform2016
27132513TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.Oncogene2016
27455875Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods.J Mol Diagn2016
27455875Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods.J Mol Diagn2016
27147817RefCNV: Identification of Gene-Based Copy Number Variants Using Whole Exome Sequencing.Cancer Inform2016
25478319Genome-wide redistribution of BRD4 binding sites in transformation resistant cells.Genom Data2015
25911752CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.J Immunol2015
25784146Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory disease.Clin Immunol2015
25478319Genome-wide redistribution of BRD4 binding sites in transformation resistant cells.Genom Data2015
25911752CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.J Immunol2015
25784146Increased CD1c+ mDC1 with mature phenotype regulated by TNFα-p38 MAPK in autoimmune ocular inflammatory disease.Clin Immunol2015
23455325Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.Oncogene2014
25371364Mesogenin 1 is a master regulator of paraxial presomitic mesoderm differentiation.Development2014
25515573Levels of blood CD1c+ mDC1 and CD1chi mDC1 subpopulation reflect disease activity in noninfectious uveitis.Invest Ophthalmol Vis Sci2014
24258200Epidermal overexpression of transgenic οNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation.J Pathol2014
23455325Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.Oncogene2014
25515573Levels of blood CD1c+ mDC1 and CD1chi mDC1 subpopulation reflect disease activity in noninfectious uveitis.Invest Ophthalmol Vis Sci2014
25371364Mesogenin 1 is a master regulator of paraxial presomitic mesoderm differentiation.Development2014
24258200Epidermal overexpression of transgenic οNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation.J Pathol2014
24098934Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development.Genome Biol2013
24098934Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development.Genome Biol2013
21576089οNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.Cancer Res2011
21576089οNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.Cancer Res2011
20531454Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function.Kidney Int2010
20978353Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.J Clin Invest2010
20531454Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function.Kidney Int2010
20978353Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.J Clin Invest2010
19037656Disruption of the Gardos channel (KCa3.1) in mice causes subtle erythrocyte macrocytosis and progressive splenomegaly.Pflugers Arch2009
19037656Disruption of the Gardos channel (KCa3.1) in mice causes subtle erythrocyte macrocytosis and progressive splenomegaly.Pflugers Arch2009
  • 1 - 50 of 72

Recommended Authors

Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
College of Bioinformatics Science and Technology, Harbin Medical University
Career Start Year 2007
Number of shared co-authors 0
Urumqi Friendship Hospital
Career Start Year 2005
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 1
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Medical University of Vienna
Career Start Year 2001
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Ningbo First Hospital, Zhejiang University
Career Start Year 2000
Number of shared co-authors 5
University of Texas Southwestern Medical Center
Career Start Year 1999
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 1
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 2
Dasman Diabetes Institute
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Merck & Co., Inc.
Career Start Year 1998
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 0
Bowdoin College
Career Start Year 1997
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Uniformed Services University of the Health Sciences
Career Start Year 1997
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 2
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 5
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 0

Collaborators

National Institute on Deafness and Other Communication Disorders
Co-authored papers 6
National Institute of Deafness and Other Communication Disorders
Co-authored papers 6
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 5
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
State University of New York at Buffalo
Co-authored papers 3
National Eye Institute
Co-authored papers 3
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Co-authored papers 3
National Eye Institute
Co-authored papers 3
Howard Hughes Medical Institute
Co-authored papers 2
The University of Hong Kong
Co-authored papers 2
Translational and Clinical Data Sciences
Co-authored papers 2
National Institute on Deafness and Other Communication Disorders
Co-authored papers 2
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Co-authored papers 2
Duke University
Co-authored papers 2
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers 2
University of North Carolina at Chapel Hill
Co-authored papers 1
Kresge Hearing Research Institute, University of Michigan ann arbor
Co-authored papers 1
Co-authored papers 1
The University of North Carolina at Chapel Hill
Co-authored papers 1
All India Institute of Medical Sciences
Co-authored papers 1
0 SW US Veterans Hospital Road
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 1
Oncology R&D Unit
Co-authored papers 1
University of Illinois at Urbana-Champaign
Co-authored papers 1
University of California at Santa Cruz
Co-authored papers 1
David Geffen School of Medicine, university of california los angeles
Co-authored papers 1
Sackler School of Medicine, Tel Aviv University
Co-authored papers 1